Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

VIII.a

Valvular heart disease and/or dysfunction

See PMID 19683643, 20716786, 23769407, 26833208

Publications

Baufreton C, Bruneval P, Rousselet MC, Ennezat PV, Fouquet O, Giraud R, Banfi C

Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.

Medicine 2017 Jan;96;e4985 — 2017 Jan — e4985

Szymanski C, Andréjak M, Peltier M, Maréchaux S, Tribouilloy C

Adverse effects of benfluorex on heart valves and pulmonary circulation.

Pharmacoepidemiology and drug safety 2014 Jul;23;679-86 — 2014 Jul — 679-86

Andrejak M, Tribouilloy C

Drug-induced valvular heart disease: an update.

Archives of cardiovascular diseases 2013 May;106;333-9 — 2013 May — 333-9

Derumeaux G, Ernande L, Serusclat A, Servan E, Bruckert E, Rousset H, Senn S, Van Gaal L, Picandet B, Gavini F, Moulin P,

Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus.

PloS one 2012;7;e38273 — 2012 — e38273

Fournier A, Zureik M

Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.

Pharmacoepidemiology and drug safety 2012 Apr;21;343-51 — 2012 Apr — 343-51

Tribouilloy C, Rusinaru D, Andréjak M

How can benfluorex-related heart valve disease be identified by echocardiography?

Archives of cardiovascular diseases 2011 Oct;104;489-92 — 2011 Oct — 489-92

Le Ven F, Tribouilloy C, Habib G, Gueffet JP, Maréchaux S, Eicher JC, Blanchard-Lemoine B, Rousseau J, Hénon P, Jobic Y, Etienne Y

Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry.

European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2011 Apr;12;265-71 — 2011 Apr — 265-71